Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02075411 · ClinicalTrials.gov registry record · Phase 3
Opioid Use in Single Shot Nerve Block vs Continuous Peripheral Nerve Infusion in Anterior Cruciate Ligament (ACL) Repair
A Phase 3 study, sponsored by Children's Hospital of Philadelphia.
- Terminated
- Registry status
- Phase 3
- Development phase
- 1
- Enrollment target
NCT02075411 is a Phase 3 study that was terminated before completion, run by Children's Hospital of Philadelphia. The registered enrollment target is 1 participants.
The verdict
NCT02075411, a Phase 3 study, was terminated before completion, sponsored by Children's Hospital of Philadelphia.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 1 participants
- Enrollment target
Study Summary
Anterior cruciate ligament repair using hamstring autograft in children is a painful orthopedic procedure. The current practice to provide analgesia for this procedure include femoral continuous perineural infusion and femoral single shot peripheral nerve block, along with perioperative opioids and NSAIDS both IV and orally. Since the use of opioids can be associated with adverse side effects, which include, but are not limited to nausea, vomiting, constipation, pruritus and respiratory depression, comparing the amount of opioid used with either analgesia delivery method is needed.
Interventions
- DRUG bupivacaine
- DEVICE continuous perineural infusion catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02075411
The ClinicalTrials.gov registry entry for NCT02075411 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which bupivacaine is the first listed.
NCT02075411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02075411 about?
NCT02075411 is a clinical study titled "Opioid Use in Single Shot Nerve Block vs Continuous Peripheral Nerve Infusion in Anterior Cruciate Ligament (ACL) Repair". Anterior cruciate ligament repair using hamstring autograft in children is a painful orthopedic procedure. The current practice to provide analgesia for this procedure include femoral continuous perineural infusion and femoral single shot peripheral nerve block, along with perioperative opioids and ...
What is the current status of trial NCT02075411?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 1 participants. The study started on 2014-03. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02075411?
The interventions under investigation include: bupivacaine (DRUG), continuous perineural infusion catheter (DEVICE).
Who is sponsoring clinical trial NCT02075411?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.